Abbisko Cayman Limited (02256)
Abbisko Cayman Limited, an investment holding company, engages in the research and development of pharmaceutical products in the People's Republic of China. The company develops Pimicotinib, which is in Phase III clinical trial for the treatment of tenosynovial giant cell tumor; Irpagratinib for the treatment of hepatocellular carcinoma; ABSK043 that is in Phase I clinical trial for the treatment of non-small cells lung can
Office
CS Hotline: +852 3018 4526
Trading days: 24 hours
Non-trading days: 9:00-18:00
Email: cs@usmarthk.com
Address: 26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp: +852 5989 2641
Physical Store
